Cargando…

A Prescription for Change : the Looming Crisis in Drug Development /

Annotation

Detalles Bibliográficos
Autor principal: Kinch, Michael, 1966- (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Chapel Hill : The University of North Carolina Press, 2018.
Colección:The Luther H. Hodges Jr. and Luther H. Hodges Sr. Series on Business, Entrepreneurship, and Public Policy Ser.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 JSTOR_on1100854570
003 OCoLC
005 20231005004200.0
006 m o d |
007 cr |||||||||||
008 180418s2018 ncu go 000 0 eng d
010 |a  2016018224 
040 |a UKAHL  |b eng  |e rda  |e pn  |c UKAHL  |d OCLCQ  |d UX1  |d OCLCF  |d HUL  |d OCLCO  |d OCLCQ 
019 |a 1100966523  |a 1175643011 
020 |a 9781469630649  |q (e-book) 
020 |a 1469630648 
020 |a 9781469630632  |q (e-book) 
020 |a 146963063X 
020 |z 9781469647579 
020 |a 1469647575  |q (Trade Paper) 
020 |a 9781469647579 
029 1 |a AU@  |b 000067032141 
035 |a (OCoLC)1100854570  |z (OCoLC)1100966523  |z (OCoLC)1175643011 
037 |b 00027332 
082 0 4 |a 615.1/9  |q OCoLC  |2 23/eng/20230216 
049 |a UAMI 
100 1 |a Kinch, Michael,  |d 1966-  |e author. 
245 1 2 |a A Prescription for Change :  |b the Looming Crisis in Drug Development /  |c Michael Kinch. 
264 1 |a Chapel Hill :  |b The University of North Carolina Press,  |c 2018. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a The Luther H. Hodges Jr. and Luther H. Hodges Sr. Series on Business, Entrepreneurship, and Public Policy Ser. 
520 8 |a Annotation  |b The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. 
590 |a JSTOR  |b Books at JSTOR All Purchased 
590 |a JSTOR  |b Books at JSTOR Evidence Based Acquisitions 
590 |a JSTOR  |b Books at JSTOR Demand Driven Acquisitions (DDA) 
650 0 |a Drugs  |x Research. 
650 0 |a Pharmaceutical industry. 
650 0 |a Pharmacology. 
650 6 |a Médicaments  |x Recherche. 
650 6 |a Industrie pharmaceutique. 
650 6 |a Pharmacologie. 
650 7 |a pharmacology.  |2 aat 
650 7 |a Drugs  |x Research.  |2 fast  |0 (OCoLC)fst00898894 
650 7 |a Pharmaceutical industry.  |2 fast  |0 (OCoLC)fst01060129 
650 7 |a Pharmacology.  |2 fast  |0 (OCoLC)fst01060259 
830 4 |a The Luther H. Hodges Jr. and Luther H. Hodges Sr. Series on Business, Entrepreneurship, and Public Policy Ser. 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.5149/9781469630632_kinch  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH32613494 
994 |a 92  |b IZTAP